Results
|
|
21.
|
Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial. [electronic resource] by
- Viallard, J F
- Agape, P
- Barlogis, V
- Cozon, G
- Faure, C
- Fouyssac, F
- Gaud, C
- Gourin, M P
- Hamidou, M
- Hoarau, C
- Husseini, F
- Ojeda-Uribe, M
- Pavic, M
- Pellier, I
- Perlat, A
- Schleinitz, N
- Slama, B
Publication details: BMC immunology Sep 2016
In:
BMC immunology vol. 17
Availability: No items available.
|
|
|
22.
|
Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes. [electronic resource] by
- Tamburini, J
- Elie, C
- Park, S
- Beyne-Rauzy, O
- Gardembas, M
- Berthou, C
- Mahe, B
- Sanhes, L
- Stamatoullas, A
- Vey, N
- Aouba, A
- Slama, B
- Quesnel, B
- Vekhoff, A
- Sotto, J J
- Vassilief, D
- Al-Nawakil, C
- Fenaux, P
- Dreyfus, F
- Bouscary, D
Producer: 20090318
In:
Leukemia research vol. 33
Availability: No items available.
|
|
|
23.
|
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases. [electronic resource] by
- Itzykson, R
- Ayari, S
- Vassilief, D
- Berger, E
- Slama, B
- Vey, N
- Suarez, F
- Beyne-Rauzy, O
- Guerci, A
- Cheze, S
- Thomas, X
- Stamatoullas, A
- Gardembas, M
- Bauduer, F
- Kolb, A
- Chaury, M C
- Legros, L
- Damaj, G
- Chermat, F
- Dreyfus, F
- Fenaux, P
- Ades, L
Producer: 20090504
In:
Leukemia vol. 23
Availability: No items available.
|
|
|
24.
|
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM. [electronic resource] by
- Kelaidi, C
- Beyne-Rauzy, O
- Braun, T
- Sapena, R
- Cougoul, P
- Adès, L
- Pillard, F
- Lamberto, C
- Lambert, C
- Charniot, J C
- Guerci, A
- Choufi, B
- Stamatoullas, A
- Slama, B
- De Renzis, B
- Ame, S
- Damaj, G
- Boyer, F
- Chaury, M P
- Legros, L
- Cheze, S
- Testu, A
- Gyan, E
- Béné, M C
- Rose, C
- Dreyfus, F
- Fenaux, P
Producer: 20130528
In:
Annals of hematology vol. 92
Availability: No items available.
|
|
|
25.
|
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion. [electronic resource] by
- Toma, A
- Kosmider, O
- Chevret, S
- Delaunay, J
- Stamatoullas, A
- Rose, C
- Beyne-Rauzy, O
- Banos, A
- Guerci-Bresler, A
- Wickenhauser, S
- Caillot, D
- Laribi, K
- De Renzis, B
- Bordessoule, D
- Gardin, C
- Slama, B
- Sanhes, L
- Gruson, B
- Cony-Makhoul, P
- Chouffi, B
- Salanoubat, C
- Benramdane, R
- Legros, L
- Wattel, E
- Tertian, G
- Bouabdallah, K
- Guilhot, F
- Taksin, A L
- Cheze, S
- Maloum, K
- Nimuboma, S
- Soussain, C
- Isnard, F
- Gyan, E
- Petit, R
- Lejeune, J
- Sardnal, V
- Renneville, A
- Preudhomme, C
- Fontenay, M
- Fenaux, P
- Dreyfus, F
Producer: 20160915
In:
Leukemia vol. 30
Availability: No items available.
|